NFE2L2 and Parkinson disease: By delineating how ferroptosis markers—Fe2*, MDA, GSH, and GPX4—are regulated in tandem with p62/Nrf2 activation, we demonstrate a previously unrecognized convergence between microglial inflammatory responses and ferroptotic vulnerabilities in the context of PD.